Antibiotic resistanceis one of the most pressing threats to public health today. Effectivelycombating multidrug-resistant bacteria requires the timely and preciseadministration of antibiotics, which depends on accurately determiningbacterial susceptibility.

BACTEROMIC is acutting-edge AST system designed to address this challenge by providingphenotypic analysis of antibiotic effectiveness. Its UNI2.0 panel is the firstand only combined panel for both gram-negative (GN) and gram-positive (GP)bacteria, featuring 31 antibiotics with 6 to 14 dilutions per drug.Additionally, a rapid AST version (6–8 hours) is in late-stage development,utilizing the same instrument with a new consumable for both isolates andpositive blood cultures.